NCT06151223 2026-03-10
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Mayo Clinic
Recruiting
Clinical Trials
28 trialsNCT02531607 2026-02-05
Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)
AdventHealth
Active not recruiting
NCT07236177 2026-02-05
B-GLUCANCER2
Poitiers University Hospital
Phase EARLY_PHASE1 Recruiting
NCT03334708 2025-12-02
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Recruiting
NCT05975593 2025-11-12
METEOR-CRATR
Washington University School of Medicine
Phase NA Recruiting
NCT06705335 2025-10-02
CONVERCAP
Institut Bergonié
Not yet recruiting
NCT04774198 2025-04-06
Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy
Rigshospitalet, Denmark
Completed
NCT04374175 2025-03-18
SERPAN
Centre Hospitalier Universitaire de Saint Etienne
Recruiting
NCT06139042 2025-02-10
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting
NCT06760741 2025-01-07
PREVENPANC
Hospital Clinic of Barcelona
Not yet recruiting
NCT03956056 2024-07-17
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Washington University School of Medicine
Phase 1 Terminated
NCT04677244 2024-04-09
EUS-CTC
Institut Paoli-Calmettes
Phase NA Recruiting
NCT05596370 2022-11-07
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer
Seoul National University Hospital
Unknown
NCT05604573 2022-11-03
DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer
Seoul National University Hospital
Unknown
NCT03978702 2022-01-06
IMMUNOPANC
Institut Paoli-Calmettes
Phase NA Unknown
NCT03787056 2021-07-16
ONCOPRO
Hospices Civils de Lyon
Phase NA Recruiting
NCT04947696 2021-07-01
Circulating Epigenetics in Pancreatic Surgery
Rigshospitalet, Denmark
Unknown
NCT04560270 2020-09-23
CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer
Poitiers University Hospital
Phase NA Completed
NCT02887599 2019-01-16
Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities
Yonsei University
Phase NA Completed
NCT02500004 2018-08-03
BAT-Cachexia
Maastricht University Medical Center
Phase NA Completed
NCT00805688 2018-03-06
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
M.D. Anderson Cancer Center
Completed
NCT01392027 2017-11-08
SPORE-PANC
University of Michigan
Phase NA Completed
NCT01794676 2017-06-16
MEN1
Jersey Shore University Medical Center
Completed
NCT01434550 2017-02-23
Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Withdrawn
NCT00225745 2015-10-14
Ghrelin Levels in Pancreatic Cancer Patients
Dartmouth-Hitchcock Medical Center
Completed
NCT01227018 2014-07-23
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated
NCT00582699 2014-04-10
Depression, Cytokines and Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Completed
NCT01031056 2012-05-28
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
Stanford University
Withdrawn